You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Serous Intraepithelial Carcinoma (STIC)

Showing 1 - 25 of 8,062
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Epithelial Cancer, Carcinoma in Situ, Ovarian Cancer Trial in Worldwide (Lavage of the Cavum uteri and proximal

Completed
  • Ovarian Epithelial Cancer
  • +2 more
  • Lavage of the Cavum uteri and proximal Fallopian tubes, performed in the luteal phase of the female cycle
  • Graz, Austria
  • +13 more
Sep 1, 2022

Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction Trial in Boston (Samples)

Not yet recruiting
  • Cancer Risk
  • +30 more
  • Samples
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 14, 2022

Ovarian Epithelial Cancer, Carcinoma in Situ, Ovarian Cancer Trial in Worldwide (Speiser-catheter for uterine and tubal lavage)

Completed
  • Ovarian Epithelial Cancer
  • +2 more
  • Speiser-catheter for uterine and tubal lavage
  • Graz, Austria
  • +8 more
Sep 1, 2022

Developing a Test for the Detection of Ovarian Cancer

Recruiting
  • Ovarian Neoplasms
  • +14 more
  • Uterine lavage, or a wash of the womb
  • +2 more
  • Little Rock, Arkansas
  • +5 more
Apr 29, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +32 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Human Papillomavirus Infection Trial in Guangzhou, Nanjing, Taiyuan (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58)

Active, not recruiting
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
  • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)（GARDASIL®）
  • Guangzhou, Guangdong, China
  • +2 more
Dec 30, 2022

Recurrent Endometrial Serous Adenocarcinoma Trial in Columbus (procedure, biological, drug)

Not yet recruiting
  • Recurrent Endometrial Serous Adenocarcinoma
  • Biospecimen Collection
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 12, 2023

Magnetic Resonance Imaging Examination Trial in Wenzhou (MRI,SCC-Ag)

Recruiting
  • Magnetic Resonance Imaging Examination
  • MRI,SCC-Ag
  • Wenzhou, Zhejiang, China
    The 2nd Affiliated Hospital and Yuying Children's Hospital of WM
Aug 3, 2022

Endometrial Cancer, Papillary Serous Endometrial Carcinoma, Uterine Serous Carcinoma Trial in United States (Niraparib)

Recruiting
  • Endometrial Cancer
  • +4 more
  • New Brunswick, New Jersey
  • +4 more
Mar 17, 2022

Uterine Serous Carcinoma Trial in Worldwide (Adavosertib)

Active, not recruiting
  • Uterine Serous Carcinoma
  • Burbank, California
  • +26 more
Jan 10, 2023

Malignant Tumors of Female Genital Organs Trial in Houston (Fulvestrant, Abemaciclib)

Active, not recruiting
  • Malignant Neoplasms of Female Genital Organs
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 5, 2022

Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma

Recruiting
  • Anal Cancer
  • Anal Squamous Intraepithelial Neoplasia
    • London, United Kingdom
      Imperial College London- Chelsea and Westminster NHS Foundation
    Apr 19, 2023

    Germline Variant Carriers With BRCA1 or BRCA2

    Recruiting
    • BRCA1 and/or BRCA2 Variant Carriers
    • +3 more
      • Okayama, Japan
        Okayama University
      Dec 25, 2022

      Low Grade Serous Ovarian Carcinoma and Uterine Involvement :

      Completed
      • Serous Ovarian Carcinoma
      • Low Grade Serous Ovarian Carcinoma
      • Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
      • Lyon, France
        Hospices civils de Lyon
      Feb 14, 2023

      Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous

      Recruiting
      • Low Grade Fallopian Tube Serous Adenocarcinoma
      • +36 more
      • Anchorage, Alaska
      • +674 more
      Nov 2, 2022

      HER2/Neu+ Uterine Serous Carcinoma Trial in Tucson, New Haven, Boston (Afatinib)

      Recruiting
      • HER2/Neu+ Uterine Serous Carcinoma
      • Tucson, Arizona
      • +2 more
      Feb 2, 2022

      Carcinoma, Neoplasia; Intraepithelial, Cervix, Glandular Tumors Trial in Havana (Glizigen® + Ocoxin-Viusid®)

      Recruiting
      • Carcinoma
      • +4 more
      • Glizigen® + Ocoxin-Viusid®
      • Havana, Cuba
        Our Lady of Rule No. 52 &/Remedios and Quiroga, Luyano
      Jul 5, 2022

      HPV Infection, HPV-Related Cervical Carcinoma Trial (FluBHPVE6E7, Placebo)

      Not yet recruiting
      • HPV Infection
      • HPV-Related Cervical Carcinoma
      • FluBHPVE6E7
      • Placebo
      • (no location specified)
      Apr 24, 2023

      Triple Negative Breast Cancer, Renal Cell Cancer, High Grade Ovarian Serous Adenocarcinoma Trial in United Kingdom

      Recruiting
      • Triple Negative Breast Cancer
      • +3 more
      • Modi-1/Modi-1v
      • +2 more
      • Brighton, Default, United Kingdom
      • +13 more
      Nov 18, 2022

      Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary Trial in Brescia, Genova (Letrozole tablets, carboplatin

      Recruiting
      • Carcinoma, Ovarian Epithelial
      • Low Grade Serous Adenocarcinoma of Ovary
      • Letrozole tablets
      • carboplatin AUC 5 and paclitaxel 175 mg/m2
      • Brescia, BS, Italy
      • +1 more
      Oct 26, 2022

      Investigate Adaptation and Evolution of Ovarian High-grade

      Recruiting
      • Ovarian Cancer
      • +6 more
        • Bristol, United Kingdom
        • +10 more
        Sep 8, 2022

        Uterine Serous Carcinoma Trial in Worldwide (ZN-c3)

        Recruiting
        • Uterine Serous Carcinoma
        • Orange, California
        • +19 more
        Feb 24, 2022

        Esophageal cAncer Screening Trial

        Completed
        • Esophageal Squamous Cell Carcinoma
        • +2 more
        • Sponge cytological test
        • Shanghai, Shanghai, China
          Changhai Hospital
        Sep 17, 2022

        Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)

        Not yet recruiting
        • Ovarian Carcinoma
        • PEP-DC1
        • +3 more
        • (no location specified)
        Jan 26, 2023

        Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta

        Completed
        • Central Serous Chorioretinopathy
        • Eplerenone , Intravitreal Aflibercept and Topical nepafenac therapy
        • Cairo, Egypt
          Kasr alainy faculty of medicine
        May 5, 2023